P2 Genomic Sequencing Resilience Capacity to the Genomics Programme
Estimated value
£12.4m
Awarded value
£12.4m
Suppliers
1
Lots
1
Published
20 Sept 2021
Description
P2 Genomic Sequencing Resilience Capacity is required to provide assurance to the Genomics Programme, to ensure efficient monitoring of variant spread, reinfections, evolution of new variants in the country and importation of variants through travel. This can also act as a resilience capacity over the winter preparation if required.
Scope
- Reference
- CF-0351900D0O000000rwimUAA1
- Total value
- £12,360,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 02 Sept 2021 to 30 Mar 2022
- CPV classifications
- 73111000
Submission & procedure
- Submission deadline
- 02 Sept 2021, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£12.4m
Award date
02 Sept 2021
Contract start
02 Sept 2021
Contract end
30 Mar 2022
Awarded suppliers· 1 supplier
Awarded 02 Sept 2021 · Contract period 02 Sept 2021 — 30 Mar 2022
Other contracts from Department of Health and Social Care (T&T)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to IMMENSA HEALTH CLINIC LTD· 10
Cross-buyer view of this supplier's public-sector wins.